IonQ, Inc. (NYSE: IONQ) is seeing expenses grow faster than revenues as the company pours capital into new technology development and platform expansion.
In the first quarter of 2026, IonQ reported an adjusted EBITDA loss of $96.8 million, signaling the scale of investment required to advance its quantum computing ambitions.
The company projects a full-year adjusted EBITDA loss of between $310 million and $330 million as it continues prioritizing research spending and business growth over near-term profitability.
Because IonQ is currently favoring investment over earnings, its valuation rests heavily on the company’s ability to sustain revenue growth and eventually generate returns that offset mounting costs.
A central risk for investors is whether management can successfully execute its technology and product roadmap, including delivering a functional 256-qubit system by the fourth quarter of 2026.
The company is pursuing a chip-based architecture to reach that milestone, and any delays in development or commercialization could slow customer adoption and extend sales cycles considerably.
Remaining performance obligations climbed to $470 million as of March 31, 2026, offering improved multi-quarter visibility, though the figure does not translate cleanly into near-term revenue due to varying delivery schedules and contract terms.
Large platform deals can expand contract value and scope, but they also tend to produce longer implementation periods, creating quarterly revenue fluctuations that complicate near-term growth assessment for investors.
IonQ currently trades at a forward 12-month price-to-sales ratio of 66.17X, a significant premium compared to the industry median of 4.36X, suggesting the market is pricing in aggressive future growth.
Over the past year, IONQ shares have gained 41.7%, lagging well behind the broader industry’s growth of 256.4%, and the stock currently carries a Zacks Rank of 4, indicating a Sell rating.
The loss per share estimate for 2026 has held steady at $1.04 over the past 30 days, reflecting analyst consensus that losses will remain elevated as the business continues scaling.
Peers in the quantum computing space face similar structural pressures, with D-Wave Quantum (NYSE: QBTS) also expecting research and development, general and administrative, and sales and marketing expenses to increase in absolute terms over the foreseeable future.
D-Wave’s revenue mix remains sensitive to the timing of larger contracts and system deliveries, a setup that can drive quarter-to-quarter volatility even when underlying bookings continue trending upward.
Rigetti Computing (NASDAQ: RGTI) faces comparable dynamics, with total operating expenses reaching $27.3 million in the first quarter of 2026 and loss from operations widening to $25.9 million from $21.6 million in the prior year period.
Across the quantum computing sector, high fixed-cost structures, long sales cycles, and technology execution risk remain defining challenges that investors must weigh carefully against long-term growth potential.
